Folding and assembly of viral membrane proteins.

PubWeight™: 4.63‹?› | Rank: Top 1%

🔗 View Article (PMID 8460475)

Published in Virology on April 01, 1993

Authors

R W Doms1, R A Lamb, J K Rose, A Helenius

Author Affiliations

1: Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.

Articles citing this

(truncated to the top 100)

The alphaviruses: gene expression, replication, and evolution. Microbiol Rev (1994) 16.68

A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J Virol (2000) 5.13

Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol (1994) 4.21

Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J Virol (1994) 3.59

A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. J Virol (1999) 3.49

Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J Virol (1994) 3.43

Der1, a novel protein specifically required for endoplasmic reticulum degradation in yeast. EMBO J (1996) 3.34

Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J Virol (1994) 3.32

Influenza A virus M2 ion channel protein: a structure-function analysis. J Virol (1994) 3.02

DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus. J Virol (2001) 2.95

Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J Virol (1997) 2.60

Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin. J Virol (1996) 2.53

The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation. J Virol (1995) 2.48

Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol (1999) 2.41

Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking. J Virol (1997) 2.34

Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport. J Virol (1994) 2.31

Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein. J Virol (1997) 2.08

Retrograde transport of Golgi-localized proteins to the ER. J Cell Biol (1998) 2.08

Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol (1999) 2.07

An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface. J Cell Biol (1996) 2.06

Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J (1995) 2.05

American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol (2003) 2.03

Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J Virol (1994) 2.00

High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells. J Virol (1994) 1.97

Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins. J Virol (2002) 1.93

A novel immunogold cryoelectron microscopic approach to investigate the structure of the intracellular and extracellular forms of vaccinia virus. EMBO J (1996) 1.88

Identification of functional regions of herpes simplex virus glycoprotein gD by using linker-insertion mutagenesis. J Virol (1994) 1.85

Oligomerization of a membrane protein correlates with its retention in the Golgi complex. J Cell Biol (1993) 1.85

The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J Cell Biol (1996) 1.83

Characterization of the putative fusogenic domain in vesicular stomatitis virus glycoprotein G. J Virol (1994) 1.75

Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits. J Virol (2000) 1.74

Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. J Virol (1997) 1.72

A new class of fusion-associated small transmembrane (FAST) proteins encoded by the non-enveloped fusogenic reoviruses. EMBO J (2000) 1.66

An unconventional role for cytoplasmic disulfide bonds in vaccinia virus proteins. J Cell Biol (1999) 1.63

Chlorella viruses. Adv Virus Res (2006) 1.63

Cross-linking of glycoprotein oligomers during herpes simplex virus type 1 entry. J Virol (1996) 1.62

Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J Virol (1995) 1.59

Identification of a membrane fusion domain and an oligomerization domain in the baculovirus GP64 envelope fusion protein. J Virol (1995) 1.58

Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein. J Virol (1996) 1.57

Recombinant rabies virus as potential live-viral vaccines for HIV-1. Proc Natl Acad Sci U S A (2000) 1.57

Influenza A virus hemagglutinin trimerization completes monomer folding and antigenicity. J Virol (2013) 1.56

Depletion of calcium from the lumen of endoplasmic reticulum reversibly inhibits passive diffusion and signal-mediated transport into the nucleus. J Cell Biol (1995) 1.55

Membrane fusion mediated by baculovirus gp64 involves assembly of stable gp64 trimers into multiprotein aggregates. J Cell Biol (1998) 1.50

Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus. J Virol (1995) 1.47

Mutations in the putative fusion peptide of Semliki Forest virus affect spike protein oligomerization and virus assembly. J Virol (1995) 1.46

Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein G. J Virol (1997) 1.43

Inhibition of immunoglobulin folding and secretion by dominant negative BiP ATPase mutants. Proc Natl Acad Sci U S A (1996) 1.41

Role of basic residues in the subgroup-determining region of the subgroup A avian sarcoma and leukosis virus envelope in receptor binding and infection. J Virol (1997) 1.40

Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. J Virol (2003) 1.38

Oligomerization and maturation of Na,K-ATPase: functional interaction of the cytoplasmic NH2 terminus of the beta subunit with the alpha subunit. J Cell Biol (1996) 1.34

Specific heterodimer formation is a prerequisite for uroplakins to exit from the endoplasmic reticulum. Mol Biol Cell (2002) 1.33

The organization of the endoplasmic reticulum and the intermediate compartment in cultured rat hippocampal neurons. Mol Biol Cell (1995) 1.32

Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies. J Virol (2006) 1.31

Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence. J Virol (1997) 1.31

Role of the stable signal peptide and cytoplasmic domain of G2 in regulating intracellular transport of the Junín virus envelope glycoprotein complex. J Virol (2006) 1.31

Membrane protein lateral interactions control Semliki Forest virus budding. EMBO J (1994) 1.31

Formation and rearrangement of disulfide bonds during maturation of the Sindbis virus E1 glycoprotein. J Virol (1994) 1.27

The oligomerization reaction of the Semliki Forest virus membrane protein subunits. J Cell Biol (1995) 1.26

The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain. J Virol (2003) 1.26

Generation of a water-soluble oligomeric ectodomain of the Rous sarcoma virus envelope glycoprotein. J Virol (1993) 1.25

Identification of the block in targeted retroviral-mediated gene transfer. Proc Natl Acad Sci U S A (1999) 1.25

Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41. Proc Natl Acad Sci U S A (2000) 1.24

Influence of N-glycans on processing and biological activity of the nipah virus fusion protein. J Virol (2004) 1.21

N-glycans of F protein differentially affect fusion activity of human respiratory syncytial virus. J Virol (2001) 1.21

Mutational analysis of the human immunodeficiency virus type 1 Vpu transmembrane domain that promotes the enhanced release of virus-like particles from the plasma membrane of mammalian cells. J Virol (1998) 1.21

Disulfide bonds in folding and transport of mouse hepatitis coronavirus glycoproteins. J Virol (1993) 1.21

Functional domains in the retroviral transmembrane protein. J Virol (1998) 1.21

The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions. J Virol (1997) 1.21

Differences in the role of the cytoplasmic domain of human parainfluenza virus fusion proteins. J Virol (1995) 1.21

Targeting of a heterodimeric membrane protein complex to the Golgi: rubella virus E2 glycoprotein contains a transmembrane Golgi retention signal. Mol Biol Cell (1995) 1.19

Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virus. J Virol (1996) 1.19

Amino acid substitutions within the leucine zipper domain of the murine coronavirus spike protein cause defects in oligomerization and the ability to induce cell-to-cell fusion. J Virol (1999) 1.19

Analysis of N-linked glycosylation of hantaan virus glycoproteins and the role of oligosaccharide side chains in protein folding and intracellular trafficking. J Virol (2004) 1.19

LDLC encodes a brefeldin A-sensitive, peripheral Golgi protein required for normal Golgi function. J Cell Biol (1994) 1.17

Functional interactions between monomers of the retroviral envelope protein complex. J Virol (1997) 1.17

Functional analysis of the transmembrane domain in paramyxovirus F protein-mediated membrane fusion. J Mol Biol (2008) 1.16

Connexin46 is retained as monomers in a trans-Golgi compartment of osteoblastic cells. J Cell Biol (1997) 1.16

Targeting of a short peptide derived from the cytoplasmic tail of the G1 membrane glycoprotein of Uukuniemi virus (Bunyaviridae) to the Golgi complex. J Virol (1998) 1.15

The small envelope glycoprotein (GS) of equine arteritis virus folds into three distinct monomers and a disulfide-linked dimer. J Virol (1995) 1.15

Lethality of PE2 incorporation into Sindbis virus can be suppressed by second-site mutations in E3 and E2. J Virol (1994) 1.14

Membrane anchoring domain of herpes simplex virus glycoprotein gB is sufficient for nuclear envelope localization. J Virol (1994) 1.14

Involvement of the molecular chaperone BiP in maturation of Sindbis virus envelope glycoproteins. J Virol (1995) 1.13

Evidence for dimerization of dimers in K+ channel assembly. Biophys J (1999) 1.12

Postoligomerization folding of human cytomegalovirus glycoprotein B: identification of folding intermediates and importance of disulfide bonding. J Virol (1995) 1.12

Phenotypic and genotypic characterization of human immunodeficiency virus type 1 CRF07_BC strains circulating in the Xinjiang Province of China. Retrovirology (2009) 1.10

Comprehensive mutational analysis of the Moloney murine leukemia virus envelope protein. J Virol (2001) 1.08

The two major envelope proteins of equine arteritis virus associate into disulfide-linked heterodimers. J Virol (1995) 1.08

The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events. J Virol (1997) 1.08

Role of lipids in virus replication. Cold Spring Harb Perspect Biol (2011) 1.08

The paramyxovirus simian virus 5 hemagglutinin-neuraminidase glycoprotein, but not the fusion glycoprotein, is internalized via coated pits and enters the endocytic pathway. Mol Biol Cell (1996) 1.08

Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41. J Virol (1996) 1.07

N-linked glycans with similar location in the fusion protein head modulate paramyxovirus fusion. J Virol (2003) 1.07

Structure of N-linked oligosaccharides attached to chlorovirus PBCV-1 major capsid protein reveals unusual class of complex N-glycans. Proc Natl Acad Sci U S A (2013) 1.07

The amino-terminal residue of Sindbis virus glycoprotein E2 influences virus maturation, specific infectivity for BHK cells, and virulence in mice. J Virol (1994) 1.05

Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor. Proc Natl Acad Sci U S A (1995) 1.05

Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles. J Virol (2000) 1.05

Differential processing of sindbis virus glycoprotein PE2 in cultured vertebrate and arthropod cells. J Virol (1996) 1.04

Role of glycoprotein PE2 in formation and maturation of the Sindbis virus spike. J Virol (1997) 1.04

Folding of rabies virus glycoprotein: epitope acquisition and interaction with endoplasmic reticulum chaperones. J Virol (1997) 1.03

Dynamic equilibrium between vesicular stomatitis virus glycoprotein monomers and trimers in the Golgi and at the cell surface. J Virol (1993) 1.03

Articles by these authors

Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell (1992) 17.81

Solubilization of membranes by detergents. Biochim Biophys Acta (1975) 13.31

On the entry of Semliki forest virus into BHK-21 cells. J Cell Biol (1980) 11.05

Acidification of the endocytic and exocytic pathways. Annu Rev Biochem (1986) 10.90

Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci U S A (1995) 9.08

Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol (2001) 8.93

Influenza virus M2 protein has ion channel activity. Cell (1992) 8.52

Protein oligomerization in the endoplasmic reticulum. Annu Rev Cell Biol (1989) 8.22

Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus G and M proteins determined from cDNA clones containing the complete coding regions. J Virol (1981) 7.97

Virus entry into animal cells. Adv Virus Res (1989) 7.78

Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J Cell Biol (1981) 7.07

5'-terminal structure of poliovirus polyribosomal RNA is pUp. Proc Natl Acad Sci U S A (1976) 6.78

Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol (1981) 6.46

Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell (1985) 6.44

Setting the standards: quality control in the secretory pathway. Science (1999) 6.41

Stepwise dismantling of adenovirus 2 during entry into cells. Cell (1993) 6.34

Membrane fusion proteins of enveloped animal viruses. Q Rev Biophys (1983) 6.31

Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J Cell Biol (1997) 5.66

Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A (1981) 5.57

Penetration of Semliki Forest virus from acidic prelysosomal vacuoles. Cell (1983) 5.46

Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription. Cell (1981) 5.38

Complete intergenic and flanking gene sequences from the genome of vesicular stomatitis virus. Cell (1980) 5.32

Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol (1988) 5.31

Pathway of vesicular stomatitis virus entry leading to infection. J Mol Biol (1982) 5.21

pH-dependent fusion between the Semliki Forest virus membrane and liposomes. Proc Natl Acad Sci U S A (1980) 5.21

Altered cytoplasmic domains affect intracellular transport of the vesicular stomatitis virus glycoprotein. Cell (1983) 5.02

Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell (1991) 4.97

Adsorptive endocytosis of Semliki Forest virus. J Mol Biol (1980) 4.94

Assembly of influenza hemagglutinin trimers and its role in intracellular transport. J Cell Biol (1986) 4.93

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell (2001) 4.79

Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol (1993) 4.76

Expression from cloned cDNA of cell-surface secreted forms of the glycoprotein of vesicular stomatitis virus in eucaryotic cells. Cell (1982) 4.74

Inhibition of translation by poliovirus: inactivation of a specific initiation factor. Proc Natl Acad Sci U S A (1978) 4.59

Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus N and NS proteins. J Virol (1981) 4.49

Membrane fusion activity of the influenza virus hemagglutinin. The low pH-induced conformational change. J Biol Chem (1985) 4.32

The gene structure and replication of influenza virus. Annu Rev Biochem (1983) 4.30

Alphavirus RNA replicase is located on the cytoplasmic surface of endosomes and lysosomes. J Cell Biol (1988) 4.27

Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc Natl Acad Sci U S A (1994) 4.25

Evidence for a ninth influenza viral polypeptide. Virology (1978) 4.21

Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell (1980) 4.18

Structural basis for paramyxovirus-mediated membrane fusion. Mol Cell (1999) 4.17

A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity. Proc Natl Acad Sci U S A (1997) 4.03

Protein-mediated membrane fusion. Annu Rev Biophys Biophys Chem (1989) 3.99

Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell (1988) 3.98

Tryptophan messenger ribonucleic acid elongation rates and steady-state levels of tryptophan operon enzymes under various growth conditions. J Mol Biol (1970) 3.89

The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J Virol (1996) 3.89

Role for adenosine triphosphate in regulating the assembly and transport of vesicular stomatitis virus G protein trimers. J Cell Biol (1987) 3.84

Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology (1991) 3.83

Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. J Virol (1989) 3.81

Glucose trimming and reglucosylation determine glycoprotein association with calnexin in the endoplasmic reticulum. Cell (1995) 3.80

Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J (2001) 3.76

Folding, trimerization, and transport are sequential events in the biogenesis of influenza virus hemagglutinin. Cell (1988) 3.73

Quality control in the secretory pathway. Curr Opin Cell Biol (1995) 3.71

Reconstitution of Semliki forest virus membrane. J Cell Biol (1977) 3.68

Quality control in the secretory pathway: retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus. J Cell Biol (1994) 3.67

Properties of detergents. Methods Enzymol (1979) 3.62

Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells. Science (1989) 3.59

Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology (1997) 3.58

Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science (1985) 3.54

Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci U S A (1996) 3.54

Fusion of Semliki forest virus with the plasma membrane can be induced by low pH. J Cell Biol (1980) 3.47

Glycoproteins of the lysosomal membrane. J Cell Biol (1985) 3.46

Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell (1997) 3.46

Heterogneeous 5'-terminal structures occur on vesicular stomatitis virus mRNAs. J Biol Chem (1975) 3.44

Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion. Nature (1982) 3.39

Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J Virol (2000) 3.39

Interactions of misfolded influenza virus hemagglutinin with binding protein (BiP). J Cell Biol (1989) 3.37

The synthesis of sendai virus polypeptides in infected cells. Virology (1976) 3.26

Intermediates in influenza induced membrane fusion. EMBO J (1990) 3.24

The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain. Cell (1989) 3.24

Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J (1997) 3.23

Polypeptides specified by the influenza virus genome I. Evidence for eight distinct gene products specified by fowl plague virus. Virology (1976) 3.20

Folding of influenza hemagglutinin in the endoplasmic reticulum. J Cell Biol (1991) 3.20

Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription. Virology (1976) 3.13

Translation of individual species of vesicular stomatitis viral mRNA. J Virol (1975) 3.12

Differential effects of mutations in three domains on folding, quaternary structure, and intracellular transport of vesicular stomatitis virus G protein. J Cell Biol (1988) 3.10

Inhibition of Semliki forest virus penetration by lysosomotropic weak bases. J Gen Virol (1982) 3.10

A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase. Proc Natl Acad Sci U S A (1983) 3.08

Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J Virol (1998) 3.07

Activation of the M2 ion channel of influenza virus: a role for the transmembrane domain histidine residue. Biophys J (1995) 3.06

Endocytosis of simian virus 40 into the endoplasmic reticulum. J Cell Biol (1989) 3.06

Attenuated vesicular stomatitis viruses as vaccine vectors. J Virol (1999) 3.04

Influenza A virus M2 ion channel protein: a structure-function analysis. J Virol (1994) 3.02

5'-Terminal nucleotide sequences of polio virus polyribosomal RNA and virion RNA are identical. Nature (1977) 3.00

Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum. EMBO J (1992) 2.99

pH-induced alterations in the fusogenic spike protein of Semliki Forest virus. J Cell Biol (1985) 2.98

Membrane fusion activity of influenza virus. EMBO J (1982) 2.97

A specific transmembrane domain of a coronavirus E1 glycoprotein is required for its retention in the Golgi region. J Cell Biol (1987) 2.97

CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J Virol (1990) 2.96

Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol (1991) 2.92

The presence of cysteine in the cytoplasmic domain of the vesicular stomatitis virus glycoprotein is required for palmitate addition. Proc Natl Acad Sci U S A (1984) 2.91

Vesicular stomatitis virus glycoprotein is anchored in the viral membrane by a hydrophobic domain near the COOH terminus. Proc Natl Acad Sci U S A (1980) 2.87

Nucleotide sequence complexities, molecular weights, and poly(A) content of the vesicular stomatitis virus mRNA species. J Virol (1975) 2.85

The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology (2001) 2.83

Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc Natl Acad Sci U S A (1984) 2.82

Translation in vitro of vesicular stomatitis virus mRNA lacking 5'-terminal 7-methylguanosine. Nature (1976) 2.81

Three-dimensional structure of endosomes in BHK-21 cells. Proc Natl Acad Sci U S A (1986) 2.81

A single N-linked oligosaccharide at either of the two normal sites is sufficient for transport of vesicular stomatitis virus G protein to the cell surface. Mol Cell Biol (1985) 2.78

Structural requirements of a membrane-spanning domain for protein anchoring and cell surface transport. Cell (1985) 2.76